Over 130,000 Olongapo residents jabbed vs COVID-19 | Inquirer News

Over 130,000 Olongapo residents jabbed vs COVID-19

Over 130,000 Olongapo residents jabbed vs COVID-19

A resident of Olongapo City is getting the first shot of Pfizer vaccine against COVID-19 during a mass vaccination at a mall. (Photo courtesy of Olongapo City Information Office)

OLONGAPO CITY—At least 132, 522 residents in this city have already received either the first or second dose of the vaccine against COVID-19, Mayor Rolen Paulino Jr. said on Wednesday (Oct. 27).

In a statement, Paulino said 57, 761, or 44 percent of the figure had been fully vaccinated, including those who received the single-dose Janssen vaccine of Johnson & Johnson.

ADVERTISEMENT

Paulino has encouraged all eligible residents, especially those 18 years old and above, to go to the Rizal Triangle covered court to get the shots.

FEATURED STORIES

He said those who have yet to register online could do so while at the vaccine site.

The city aims to inoculate 70 percent or 182,000 of its 260,000-population to achieve herd immunity against the viral disease.

As of Tuesday, the city’s active COVID-19 cases further dropped to 113 after recording only three new infections and five more recoveries.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Olongapo

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.